Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion.

MACROPHAGES; ANTIGEN presenting cells; CONNECTIVE tissue cells; CELLULAR immunity; CHOROID plexus; VIRUS diseases; ENZYME inhibitors; WEST Nile virus; ANIMAL experimentation; BRAIN; COMPARATIVE studies; ENZYMES; LYMPHOKINES; RESEARCH methodology; MEDICAL cooperation; MICE; RESEARCH; RESEARCH funding; VIRUSES; WEST Nile fever; VIRAL load; EVALUATION research; CHEMICAL inhibitors; PHYSIOLOGY

The flavivirus West Nile virus (WNV) is an emerging pathogen that causes life-threatening encephalitis in susceptible individuals. We investigated the role of the proinflammatory cytokine macrophage migration inhibitory factor (MIF), which is an upstream mediator of innate immunity, in WNV immunopathogenesis. We found that patients suffering from acute WNV infection presented with increased MIF levels in plasma and in cerebrospinal fluid. MIF expression also was induced in WNV-infected mice. Remarkably, abrogation of MIF action by 3 distinct approaches (antibody blockade, small molecule pharmacologic inhibition, and genetic deletion) rendered mice more resistant to WNV lethality. Mif(-/-) mice showed a reduced viral load and inflammatory response in the brain when compared with wild-type mice. Our results also indicate that MIF favors viral neuroinvasion by compromising the integrity of the blood-brain barrier. In conclusion, the data obtained from this study provide direct evidence for the involvement of MIF in viral pathogenesis and suggest that pharmacotherapeutic approaches targeting MIF may hold promise for the treatment of WNV encephalitis. [ABSTRACT FROM AUTHOR]